glp 1 based therapeutics summit What an amazing Day Two we've had here at the 3rd Annual glp 1 summit Meet with
Description
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health care spending.
Current expectations point to FDA review and potential approval in the 2027 to 2028 range
Learn key insights from Springbuk's 2024 Employee Health Trends update on managing expenses while prioritizing employee well-being.
Discover the evidence on GLP-1s and vision loss, who's at risk, warning signs to watch for, and how to protect your eyesight whilst taking these diabetes and weight-loss treatments.
Fasting or postprandial secretin concentrations showed no significant changes
